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The permeability transition (PT) denotes an increase of the mitochondrial inner membrane
permeability to solutes with molecular masses up to about 1500 Da. It is presumed
to be mediated by opening of a channel, the permeability transition pore (PTP), whose
molecular nature remains a mystery. Here I briefly review the history of the PTP, discuss
existing models, and present our new results indicating that reconstituted dimers of the
FOF1 ATP synthase form a channel with properties identical to those of the mitochondrial
megachannel (MMC), the electrophysiological equivalent of the PTP. Open questions
remain, but there is now promise that the PTP can be studied by genetic methods to
solve the large number of outstanding problems.
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THE MITOCHONDRIAL PERMEABILITY TRANSITION
The permeability transition (PT) defines an increase of mito-
chondrial inner membrane permeability to ions and solutes
with molecular masses up to about 1500 Da leading to matrix
swelling. The occurrence of swelling in isolated mitochondria, its
strict dependence on matrix Ca2+, stimulation by Pi and fatty
acids, and inhibition by Mg2+ and adenine nucleotides has been
recognized very early (Raaflaub, 1953a,b; Brenner-Holzach and
Raaflaub, 1954; Hunter and Ford, 1955; Tapley, 1956; Lehninger,
1959; Lehninger and Remmert, 1959; Wojtczak and Lehninger,
1961; Zborowski and Wojtczak, 1963; Azzi and Azzone, 1965;
Azzone and Azzi, 1965; Chappell and Crofts, 1965; Crofts and
Chappell, 1965); and its detrimental effects on energy conserva-
tion have been described before the emergence of chemiosmotic
concepts (Mitchell, 1961, 2011). As a result, the PT has initially
been considered an in vitro artifact of questionable pathophys-
iological relevance, although a few Authors did recognize its
potential importance in pathophysiology (Rasola and Bernardi,
2007).
Pfeiffer and Coworkers suggested that the permeabilizing
effect of Ca2+ had a physiological role in steroidogenesis. These
Authors showed that Ca2+ induces a “transformation” of adrenal
cortex mitochondria allowing diffusion of extramitochondrial
pyridine nucleotides through the otherwise impermeable inner
membrane, and that NADPH entering in this way supports the
11-β hydroxylation of deoxycorticosterone (Pfeiffer and Tchen,
1973, 1975; Pfeiffer et al., 1976). These findings match those of
Vinogradov et al., who demonstrated the Ca2+-dependent release
of matrix pyridine nucleotides in liver mitochondria (Vinogradov
et al., 1972). The term “permeability transition” was introduced
by Haworth and Hunter, who thoroughly characterized its basic
features in heart mitochondria. These Authors provided the key
insight that the PT was due to reversible opening of a proteina-
ceous pore in the inner mitochondrial membrane, the perme-
ability transition pore (PTP), whose physiological role remained
undefined (Hunter et al., 1976; Hunter and Haworth, 1979a,b;
Haworth and Hunter, 1979).
Studies on the PT were not too popular at this time, a possi-
ble consequence of the general acceptance of the chemiosmotic
hypothesis which had just been fully recognized with the award
of the Nobel Prize to Peter Mitchell in 1978. As noted earlier
(Bernardi, 1999) studies of mitochondrial ion transport were
indeed carried out in the same laboratories involved in clarify-
ing the mechanisms of energy conservation, and they tended to
become tests of the predictions of the chemiosmotic theory. In
retrospect it is not too surprising that the existence of a large pore
in the inner membrane appeared to contradict the basic tenets
of chemiosmosis. As a result, and with very few exceptions (see
e.g., Beatrice et al., 1980; Coelho and Vercesi, 1980; Bernardi and
Pietrobon, 1982; Lê-Quôc and Lê-Quôc, 1982, 1985; Siliprandi
et al., 1983; Vercesi, 1984; Riley and Pfeiffer, 1985; Al Nasser and
Crompton, 1986; Sokolove and Shinaberry, 1988) research in this
area did not enjoy much popularity.
The discovery that in mammalian mitochondria the PT can be
inhibited by submicromolar concentrations of cyclosporin (Cs)
A (Fournier et al., 1987; Crompton et al., 1988; Broekemeier
et al., 1989; Davidson and Halestrap, 1990) changed the field
substantially. CsA inhibits the PTP after binding to matrix
cyclophilin (CyP)D, a peptidyl-prolyl cis-trans isomerase (PPIase)
whose enzymatic activity is blocked by CsA (Fischer et al.,
1989; Takahashi et al., 1989) in the same range of concentra-
tions inhibiting the pore (Connern and Halestrap, 1992, 1994;
Nicolli et al., 1996; Woodfield et al., 1997). A second funda-
mental finding was the demonstration that mitochondria possess
ion channels that can be studied by electrophysiology (Sorgato
et al., 1987). This seminal study was soon followed by the demon-
stration that the inner mitochondrial membrane is endowed
with a high-conductance (≈1–1.3 nS) channel, the “mitochon-
drial megachannel” (MMC) (Kinnally et al., 1989; Petronilli et al.,
1989). The MMC is inhibited by CsA (Szabó and Zoratti, 1991)
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and possesses all the key regulatory features of the PTP (Bernardi
et al., 1992; Szabó et al., 1992) leaving little doubt that the PTP
and theMMC are two aspects of the samemolecular entity (Szabó
and Zoratti, 1992). Electrophysiology has greatly contributed to
our understanding of the MMC–PTP, and to acceptance of the
pore theory of the PT (Zoratti et al., 2005).
Involvement of the PT in cell death was hypothesized 25 years
ago (Crompton and Costi, 1988). Early support was obtained in
hepatocytes subjected to oxidative stress (Broekemeier et al., 1992;
Imberti et al., 1992), anoxia (Pastorino et al., 1993), or treatment
with ATP (Zoeteweij et al., 1993); and in cardiomyocytes (Duchen
et al., 1993) and isolated hearts (Griffiths and Halestrap, 1995)
exposed to ischemia followed by reperfusion. The exponential
increase in experimental papers dealing with the PT as an effector
mechanism of cell death, however, only followed the demonstra-
tion that in the course of apoptosis cytochrome c is released into
the cytosol (Liu et al., 1996) together with apoptosis-inducing fac-
tor (Susin et al., 1996) and a set of other proteins involved in the
effector phase of apoptosis (Du et al., 2000; Ekert et al., 2000;
Hegde et al., 2001; Li et al., 2001).
The molecular basis of the PT is still the matter of conjectures
(Siemen and Ziemer, 2013). The various models and working
hypotheses proposed over the years had to cope with the lack of
selectivity for the permeating species, the strict requirement for
matrix Ca2+, which has recently been established also for yeast
mitochondria (Yamada et al., 2009), the stimulation by oxidants,
the existence of a vast number of “inducers” without common
structural features, and of a more limited but still substantial
number of inhibitors (Gunter and Pfeiffer, 1990).
MANY SUSPECTS, NO CULPRITS
ADENINE NUCLEOTIDE TRANSLOCATOR, VDAC, AND CONTACT SITES
Inhibition of mitochondrial swelling by adenine nucleotides has
long been appreciated (Raaflaub, 1953b; Brenner-Holzach and
Raaflaub, 1954), but the idea that the adenine nucleotide translo-
cator (ANT) is causally involved in the PT probably originates
from the finding that Ca2+-dependent membrane permeabiliza-
tion is affected by the ANT inhibitors atractylate and bongkrekate,
atractylate being a PT inducer and bongkrekate a PT inhibitor
(Hunter and Haworth, 1979a). While early studies concluded
(correctly, as it turns out) that the PT is an innermembrane event,
the outer membrane was called into the picture after the work
of Brdiczka and coworkers on inner-outer membrane contact
sites, i.e., specialized structures where the two membranes form
close contacts mediated by protein–protein interactions (Kottke
et al., 1988). The contact sites were proposed to facilitate chan-
neling of adenine nucleotides to and from mitochondria, and to
comprise hexokinase on the cytosolic surface and VDAC within
the outer membrane, creatine kinase and nucleoside diphosphate
kinase (in tissues that express these proteins), and ANT in the
inner membrane (Adams et al., 1989; Bucheler et al., 1991). The
connection with the PTP was made in 1996, when the same labo-
ratory found that hexokinase-enriched fractions formed channels
with the conductance expected of the PTP, and conferred per-
meability properties to liposomes that could be inhibited by
N-methylVal-4-cyclosporin (Beutner et al., 1996). Unlike the case
of MMC, however, currents were inhibited rather than induced
by atractylate; the active fractions were not enriched in VDAC
or ANT; and the preparation contained a very large number of
proteins (Beutner et al., 1996) making assignment of the chan-
nel activity to a specific species quite problematic. The same
hexokinase-enriched fractions were used to study the interactions
with proteins of the Bcl-2 family (Marzo et al., 1998). The hex-
okinase/VDAC/ANT model of the PTP was extended to include
outer membrane TSPO [formerly known as peripheral benzodi-
azepine (Bz) receptor] and Bcl-2 family members (Zamzami and
Kroemer, 2001). No further progress wasmade in the purification
of the component(s) mediating channel activity and membrane
permeabilization, yet this model became widely accepted as the
“structure” of the PTP.
WHAT DIDWE LEARN FROM GENETIC INACTIVATION OF PUTATIVE PTP
COMPONENTS
Conclusive evidence that the ANT is not essential for PTP for-
mation comes from analysis of mitochondria lacking all ANT
isoforms, which revealed that a Ca2+-dependent PT took place
(Kokoszka et al., 2004). The PT could be inhibited by CsA and
triggered by thiol oxidants, demonstrating that the ANT is nei-
ther the obligatory binding partner of CyPD nor the site of action
of oxidants (Kokoszka et al., 2004) as suggested earlier (Costantini
et al., 1998). In addition, hepatocytes prepared from control and
ANT-deficient livers showed identical responses to activation of
receptor-mediated apoptotic pathways initiated by TNFα and Fas
(Kokoszka et al., 2004). It has been argued that a low, undetectable
level of ANT expression could explain the PT observed in ANT-
null mitochondria (Halestrap, 2004). I believe that this possibility
is quite remote because the PTP of mitochondria lacking ANT
was insensitive to opening by atractylate and to closure by ADP
(Kokoszka et al., 2004). As noted elsewhere (Bernardi et al., 2006)
it is very difficult to envisage how any ANT molecules present in
mutant mitochondria would promote a CsA-sensitive PT and yet
not respond to atractylate and ADP.
A detailed comparison of the PT in mitochondria from wild-
type and Vdac1−/− mice demonstrated that VDAC1 is fully dis-
pensable for PTP opening and regulation (Krauskopf et al., 2006).
Furthermore, the PT of mitochondria prepared from Vdac3−/−
and Vdac1−/−Vdac3−/− mice, or from fibroblasts lacking all
three VDAC isoforms, was identical to that of strain-matched
wild-type mitochondria (Baines et al., 2007). Taken together,
these results clearly indicate that VDACs are not components of
the PTP although, as discussed later in the review, the outer mem-
brane appears to participate in PTP regulation (Sinha Roy et al.,
2009; Šileikyte et al., 2011).
TSPO is an 18 kDa highly hydrophobic protein, involved in
cholesterol and protophorphyrin transport, which is located in
the outer mitochondrial membrane (Batarseh and Papadopoulos,
2010). It was initially identified as a binding site for Bz in tis-
sues that lack GABA receptors (Anholt et al., 1985, 1986). TSPO
binds with nM affinity a variety of ligands, notably the Bz Ro5-
4864 and the isoquinoline carboxamide PK11195 (Verma et al.,
1987) as well as protoporphyrin IX, a potent inducer of the PTP
(Pastorino et al., 1994). Treatment with TSPO ligands does affect
the channel activity of the MMC–PTP in the proper concen-
tration range (Kinnally et al., 1993) but TSPO is not the only
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mitochondrial protein binding these compounds, which have
been shown to interact with, and inhibit, the FOF1 ATP syn-
thase (Cleary et al., 2007). The latter finding acquires a particular
meaning in the light of our recent demonstration that FOF1 ATP
synthase dimers form channels indistinguishable from the PTP
that can be activated by Bz-423 (Giorgio et al., 2013). Perhaps
not surprisingly then, the PTP of mitochondria from mice where
expression of TSPO had been conditionally inactivated could still
be sensitized to Ca2+ by TSPO ligands, and had general fea-
tures indistinguishable from those of mitochondria isolated from
mice with wild-type genotype (Šileikyte˙, Forte et al., unpublished
observations).
In summary, what we learned from gene inactivation studies is
that none of the channel-forming proteins suggested to take part
in PTP formation is necessary for its occurrence.
ALTERNATIVEMODELS FOR PTP FORMATION
The Halestrap laboratory has proposed a new model for the PTP
that envisions the formation of a pore by the Pi carrier (Leung
et al., 2008). PTP formation would be favored by Ca2+ and CyPD
binding, and the open probability would be increased by forma-
tion of a heterodimer with the ANT (Leung and Halestrap, 2008).
Thismodel still needs to be tested by reconstitution and by genetic
means, but it should be noted that patch-clamp experiments
with the functionally active mitochondrial Pi carrier revealed an
anion-selective channel function with a mean conductance as low
as 40 pS (the typical conductance of the PTP is 1.0 − 1.3 nS, and
the channel is not ion-selective). Furthermore, the current was
decreased to 25 pS by both Ca2+ (which activates the PTP) and
Mg2+ (which inhibits it). Finally, and at striking variance with
the pore, channel activity was inhibited by Pi and unaffected by
ADP (Herick et al., 1997). These features make the Pi carrier a
very unlikely candidate as a PTP component.
A radically different model of the PTP has been proposed in
which the pore does not form from a specific protein but rather
from aggregation of misfolded integral membrane proteins dam-
aged by oxidant and other stresses (Kowaltowski et al., 2001; He
and Lemasters, 2002). In the hypothesis of He and Lemasters
conductance through misfolded protein clusters would be nor-
mally blocked by chaperone-like proteins (including CyPD) and
modulated by Ca2+ and CsA. Opening of “unregulated” pores
would occur when protein clusters exceed available chaperones
(He and Lemasters, 2002). This model fails to account for the
absolute Ca2+ requirement of PTP, and its regulation by voltage
(Bernardi, 1992), matrix pH (Nicolli et al., 1993), and adenine
nucleotides, all effects that are not easy to reconcile with a per-
meability pathway created by a heterogeneous set of denatured
proteins.
It should be mentioned that Ca2+-dependent, CsA-insensitive
PT-like channel activities have been described that are formed
or activated by 3-hydroxybutyrate/polyphosphate (Pavlov et al.,
2005) and by fatty acids (Mironova et al., 2001; Sultan and
Sokolove, 2001). The latter observation links to early work
demonstrating that fatty acids are potent inducers of mitochon-
drial swelling (Lehninger and Remmert, 1959; Wojtczak and
Lehninger, 1961), which was later recognized to be due to PTP
opening (Scorrano et al., 2001; Bernardi et al., 2002).
CYCLOPHILIN D AND FOF1 ATP SYNTHASE
CyPs are ubiquitous, conserved proteins possessing PPIase activ-
ity (Fischer et al., 1989; Takahashi et al., 1989) sharing a common
domain of about 109 amino acids, the CyP-like domain (Wang
andHeitman, 2005). In man 16 unique CyPs have been found, the
prototype being cytosolic CyPA (Wang and Heitman, 2005). After
binding CsA the PPIase activity is inhibited (Borel et al., 1977)
and the CsA/CyPA complex binds to and inhibits the cytosolic
phosphatase calcineurin (Liu et al., 1991), causing immunosup-
pression (Clipstone and Crabtree, 1992; Walsh et al., 1992).
CyPD is the mitochondrial CyP isoform in mammals
(Connern and Halestrap, 1992; Nicolli et al., 1996; Woodfield
et al., 1997), see Giorgio et al. (2010) for a review. Much on
its role in PTP regulation has been learned by genetic ablation
of the Ppif gene (which encodes for CyPD). CyPD is the mito-
chondrial receptor for CsA and modulates the PTP but is not
a structural pore component (Baines et al., 2005; Basso et al.,
2005; Nakagawa et al., 2005; Schinzel et al., 2005). As discussed
elsewhere (Bernardi et al., 2006), the effect of CsA on the PTP
is best described as “desensitization” in the sense that the PTP
becomes more resistant to opening by Ca2+ and Pi. It should be
stressed that pore opening readily takes place for Ca2+-Pi loads
that are about twice those required in wild-type mitochondria.
This indicates that Ppif−/− (CyPD-null) mitochondria are not null
for the PTP. This consideration is important for the interpreta-
tion of results obtained with CsA because (similarly to the absence
of CyPD) CsA can desensitize but not block the PTP; thus, lack of
sensitivity to CsA does not necessarily mean that the PTP is
not involved in the event being studied. Furthermore, expres-
sion of CyPD is modulated, e.g., by muscle denervation (Csukly
et al., 2006), and only CyPD-expressing mitochondria respond to
CsA (Li et al., 2012). No endogenous ligands of CyPD mimick-
ing the effects of CsA are known, but other PTP (de)sensitizers
might act by favoring CyPD association or dissociation, as docu-
mented for acidic pH and increasing ionic strength (Nicolli et al.,
1996). Furthermore, CyPD phosphorylation (Rasola et al., 2010),
acetylation (Shulga and Pastorino, 2010), and nitrosylation (Kohr
et al., 2011; Nguyen et al., 2011) affect the propensity of the
PTP to open (Rasola and Bernardi, 2011). Not surprisingly CyPD
may interact with many proteins including Hsp90 and its related
molecule TRAP-1 (Kang et al., 2007); Bcl-2 (Eliseev et al., 2009);
ERK-2/GSK-3 (Rasola et al., 2010); possibly p53 (Vaseva et al.,
2012), but see (Karch and Molkentin, 2012); and the FOF1 ATP
synthase (Giorgio et al., 2009). The latter interaction turned out
to be the key for identification of the PTP.
The FOF1 ATP synthase (or complex V) is the rotary enzyme
that synthesizes the vast majority of ATP in respiring cells (Rees
et al., 2009). It is formed by the catalytic F1, themembrane-bound
proton-translocating FO, and the lateral stalk linking F1 and FO
(Strauss et al., 2008; Thomas et al., 2008; Rees et al., 2009; Baker
et al., 2012; Davies et al., 2012) (Figure 1). The lateral stalk acts
as a stator preventing the α3β3 subcomplex of F1 from rotating
with subunits γ, δ, and ε and the ring of FO-subunits c (Rees
et al., 2009). The FOF1 ATP synthase complex associates to form
dimers, which are considered to be the “building blocks” of long
rows of oligomers that promote cristae formation and may opti-
mize the enzyme’s catalytic performance (Campanella et al., 2008;
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FIGURE 1 | Schematic representation of FOF1 ATP synthase dimers.
F1 (dark blue), FO (green and light blue), and stalk subunits (red) are
illustrated based on recent structural studies (Strauss et al., 2008; Baker
et al., 2012; Davies et al., 2012).
Strauss et al., 2008; Thomas et al., 2008; Rees et al., 2009; Baker
et al., 2012; Davies et al., 2012). The angle formed by the dimers
seems to display a large variability, and dimers are believed to rep-
resent the physiological unit of complex V in the innermembrane
(Thomas et al., 2008).
We found that CyPD binds the lateral stalk of complex V in
an apparent ratio of 1:1:1:1 with the OSCP, b and d subunits
(Giorgio et al., 2009). CyPD binding requires Pi and results in
partial inhibition of ATP synthase activity, while CsA displaces
CyPD resulting in enzyme reactivation (Giorgio et al., 2009). The
stimulatory effect of CsA on enzyme catalysis is lost in Ppif−/−
mitochondria, proving that it is mediated by CyPD, while assem-
bly of the ATP synthase is not affected by CyPD ablation (Giorgio
et al., 2009). In spite of the striking analogies with PTP regula-
tion (Pi dependence, CsA sensitivity) whether the interactions of
CyPD with complex V are relevant for the PT remained unknown
until very recently.
DIMERS OF FOF1 ATP SYNTHASE FORM CHANNELS
INDISTINGUISHABLE FROM THE MMC–PTP
We have defined the binding site of CyPD on ATP synthase to
the OSCP subunit, and shown that the interaction is electro-
static in nature. Modeling of surface potentials and isopotential
curves suggested that CyPD interacts with OSCP in a region over-
lapping with helices 3 and 4, and this turned out to be a key
insight (Giorgio et al., 2013). Indeed, this is also the binding
site of Bz-423, a well-characterized inhibitor of the FOF1 ATP
synthase (Johnson et al., 2005; Stelzer et al., 2010). If the CyPD
interactions are important for the PT, it was logical to expect
that Bz-423 should act as a PTP inducer, and this was the case.
Bz-423 sensitized the PTP to Ca2+, and the inducing effect was
blunted by Pi at concentrations that increase CyPD binding to
OSCP (Giorgio et al., 2013). Consistent with an involvement of
complex V in PTP formation, decreased levels of OSCP did affect
the Ca2+ dependence of the pore. Indeed, mitochondria took up
Ca2+ normally when ATP was used as the energy source, but the
threshold Ca2+ load required for PTP opening was halved, which
is the first molecular evidence that OSCP affects the probability of
pore opening. Consistent with a key role of the ATP synthase, the
Ca2+ affinity of the PTP was also affected by enzyme catalysis in
the sense that ATP-hydrolyzing mitochondria required twice the
Ca2+ load of ATP-synthesizingorganelles, an effect as large as that
of CsA (Giorgio et al., 2013).
Direct evidence that the PTP forms from the FOF1 ATP syn-
thase was obtained by incorporating dimers purified by blue
native electrophoresis into azolectin bilayers, and by measuring
the passage of currents after application of a voltage difference.
Addition of Bz-423 in the presence of Ca2+ triggered opening
of high-conductance channels that were blocked by Mg2+/ADP
and by the ATP synthase inhibitor AMP-PNP (γ-imino ATP,
a non hydrolyzable ATP analog). Monomers of ATP synthase
were devoid of channel activity in spite of the same overall sub-
unit composition as the dimers (Tomasetig et al., 2002; Giorgio
et al., 2013). The characteristics of the reconstituted pore closely
matched those of MMC–PTP (Petronilli et al., 1989; Szabó and
Zoratti, 1991; Szabó et al., 1992). Maximal chord conductance
was between 1.0 and 1.3 nS in symmetrical KCl 150mM, and
various subconductance states were observed. Like the MMC of
Ppif−/− mitochondria (De Marchi et al., 2006), and in keeping
with the lack of CyPD in the preparations, the channel was insen-
sitive to CsA. Ca2+ and Pi, which sensitize the PTP even in the
absence of CyPD, sufficed to induce PTP currents when dimers
were prepared in the presence of 10mM Pi. Channel openings
could not be elicited by atractyloside and, once elicited by Bz-423,
were still observed in the presence of bongkrekic acid. These find-
ings are consistent with the absence of ANT in the preparations,
which also totally lacked VDAC (Giorgio et al., 2013).
Bz-423 was characterized as an apoptosis-inducing agent act-
ing through mitochondria (Blatt et al., 2002) and OSCP was
identified as its target through the unbiased screening of a
human phage display library (Johnson et al., 2005). The selec-
tivity of action of Bz-423 on OSCP, its ability to trigger chan-
nel activity of ATP synthase dimers, and the lack of activity
of monomer preparations strongly argues against the possibil-
ity that the currents observed by Giorgio et al. (2013) are due
to unidentified contaminating proteins. The PTP-inducing effect
of Bz-423 and CyPD (which both act through OSCP on top
of the lateral stalk in the matrix) must be indirect, as it affects
the permeability properties of the inner membrane. We assume
that the PTP forms at the membrane interface between two
adjacent FO sectors, which could also accommodate the effects
of fatty acids (Lehninger and Remmert, 1959; Wojtczak and
Lehninger, 1961; Bernardi et al., 2002). Matrix Ca2+ has an
essential permissive role in PTP formation, and we have sug-
gested that accessibility of Ca2+ to the metal binding sites of
the catalytic F1 sector is influenced by OSCP. This subunit could
indeed affect the affinity of the metal binding sites of ATP syn-
thase and thus determine the ease with which matrix Ca2+ can
replace Mg2+ causing PTP opening. Our working hypothesis
is that OSCP as such is a “negative” modulator, whose effect
can be counteracted by binding of the “positive” effector CyPD
(which indeed increases the apparent Ca2+ affinity of the PTP).
Removal of OSCP, or CyPD binding to OSCP, would induce
similar conformational effects leading to increased probability
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of PTP opening, a working hypothesis that awaits experimental
verification.
A cartoon with the hypothetical events leading to PTP for-
mation from complex V dimers is presented in Figure 2. In the
“coupled” condition the dimers bind Mg2+-ADP/ATP, and the
concentration of free Ca2+ (and Pi, not shown in the Figure)
is not high enough for the PT to occur (panel A). Binding of
CyPD, which is favored by Pi (Giorgio et al., 2009), would cause a
conformational change affecting accessibility of the metal bind-
ing sites. This in turn would decrease the matrix Ca2+ load
necessary to trigger the PT (panels B,D). The transition would
essentially depend on replacement of Mg2+ with Ca2+, which in
the absence of CyPD binding would require higher matrix Ca2+
loads (panel C). Accessibility of the metal binding site (and prob-
ability of occurrence of the PT at a given Ca2+ load) would be
increased by thiol oxidation and counteracted by thiol reduc-
tion. Ion and solute permeation would then occur at the interface
between the c rings (panels C,D). The PT can be fully reverted by
Ca2+ chelation with EGTA (Petronilli et al., 1994), which would
restore Mg2+ binding and allow the dimer to recover the coupled
structure.
A MYSTERY SOLVED, MORE MYSTERIES TO SOLVE
ROLE OF OUTER MEMBRANE
It can no longer be questioned that the PT is an inner membrane
event since (1) complex V dimers suffice to induce MMC activity
and (2) Ca2+-dependent PT occurs in mitoplasts, i.e., mitochon-
dria stripped of the outer membrane (Šileikyte et al., 2011). These
findings should not be taken to imply that the outer membrane
does not play a role in PTPmodulation, which is in fact supported
by a large number of studies. An early indication was provided by
Lê-Quôc and Lê-Quôc, who showed that induction of the PTP by
substituted maleimides requires the outer membrane (Lê-Quôc
and Lê-Quôc, 1985). We have fully confirmed this “sensitizing”
role of the outer membrane by an independent approach, i.e.,
irradiation of mitochondria with visible light after treatment with
hematoporphyrin, a strategy that allows production of singlet
oxygen leading to PTP inactivation or reactivation depending on
the light dose (Ricchelli et al., 2011). Low light doses inactivate
the PTP through degradation of hystidyl residues that prevent
cysteine oxidation on the matrix side (Salet et al., 1997), while
higher light doses activate the PTP through cysteine oxidation at
the outer membrane (Moreno et al., 2001; Petronilli et al., 2009).
Mitoplasts are completely resistant to PTP induction by high light
doses (Šileikyte et al., 2011) proving that the outer membrane
can favor PTP opening through a still unidentified mechanism
(Ricchelli et al., 2011).
Bcl-2 family proteins, which are generally believed to locate to
the outer membrane, affect the PTP (Forte and Bernardi, 2006).
According to several studies Bcl-2 increases resistance to the PT
(Susin et al., 1996; Decaudin et al., 1997) while Bax and/or Bad
activated by tBid favor PTP opening (Pastorino et al., 1998, 1999;
Scorrano et al., 2002; Sinha Roy et al., 2009). Although CsA did
not prevent cytochrome c release in one study where tBid was
used, it is not known whether the cells expressed CyPD and were
therefore sensitive to CsA inhibition (Garcia-Perez et al., 2012), an
FIGURE 2 | Hypothetical transition of FOF1 ATP synthase dimers to form
the PTP. ATP synthase dimers (A) can undergo PTP formation when Ca2+
rather thanMg2+ is bound,possibly at the catalytic sites, in a reversible process
favored by thiol oxidation (C). Binding of CyPD, which is favored by Pi (B)would
increase the accessibility of the metal binding sites, allowing PTP formation at
lowerCa2+ concentrations (asdepictedherebyasmaller face type) (D).Adenine
nucleotides counteract PTP formation in synergy with Mg2+. Red arrows
denote the hypothetical pathway for solute diffusion between two FO subunits.
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issue thatmay explain discrepancies with earlier studies (Scorrano
et al., 2002; Tafani et al., 2002). Occurrence of a PT is instead
opposed by outer membrane binding of hexokinase II (Pastorino
et al., 2002, 2005; Chiara et al., 2008), which counteracts the
inducing effects of Bax (Pastorino et al., 2002). It must be men-
tioned that Bcl-2 family proteins also interact with other targets.
Indeed, tBid initiates a CsA-sensitive process of cristae remodel-
ing that increases cytochrome c availability in the intermembrane
space, which is consistent with a PT-dependent facilitation of
cytochrome c release even when the outer membrane is intact
(Scorrano et al., 2002, 2003); and Bax inhibits the mitochondrial
inner membrane potassium channel Kv1.3 (Szabó et al., 2008), a
proapoptotic effect that critically depends on Bax residue K128
and is abrogated by a K128E mutation, while an E158K muta-
tion in antiapoptotic Bcl-xL (position 158 of Bcl-xL corresponds
to position 128 of Bax) turns Bcl-xL into a proapoptotic protein
(Szabó et al., 2011).
The detailed mechanisms through which the outer membrane
affects formation of the PTP remain to be addressed. I would
like to stress that the vast majority of complex V is located in
long rows of oligomers deep inside mitochondrial cristae (Strauss
et al., 2008; Davies et al., 2011, 2012) where direct physical inter-
action with the outer membrane is obviously not possible. Thus,
either the PTP forms in the small population of dimers facing
the intermembrane space, where direct contact with the outer
membrane can occur; or the effect is exerted by controlling the
diffusion of PTP-regulating metabolites and ions including Ca2+
itself (Madesh and Hajnoczky, 2001; Rapizzi et al., 2002) in a pro-
cess that would be greatly favored by cristae remodeling (Scorrano
et al., 2002).
THE PTP AS A CALCIUM RELEASE CHANNEL
We have recently reviewed the hypothesis (Bernardi and
Petronilli, 1996; Ichas et al., 1997) that the PTP may open tran-
siently (Hüser et al., 1998; Hüser and Blatter, 1999; Petronilli et al.,
1999, 2001) to operate as a mitochondrial Ca2+ release chan-
nel under physiological conditions (Bernardi and von Stockum,
2012). The basis for this hypothesis goes back to 1992, when
Altschuld et al. reported that CsA significantly increases net Ca2+
uptake and decreases Ca2+ efflux in isolated cardiomyocytes,
as measured by radiolabeled 45Ca2+, through a demonstrably
mitochondrial effect that has no impact on cell morphology or
viability (Altschuld et al., 1992). Three recent publications based
on Ppif−/− cells and mice support this hypothesis (Elrod et al.,
2010; Barsukova et al., 2011; Parone et al., 2013).
An age-related phenotype was discovered in the hearts of
Ppif−/− mice, which dysplayed decreased contractile reserve and
increased shortening and relaxation times, with longer decay of
cytosolic Ca2+ transients (Elrod et al., 2010). Direct measure-
ment of total mitochondrial Ca2+ content of Ppif−/− hearts
showed a 2.6-fold increase, which was matched by larger Ca2+
transients in mitochondria of myocytes treated with CsA. Under
continuous pacing PTP desensitization with CsA decreased the
rise time in Ca2+ accumulation and prolonged the recovery
time after pacing, findings that are entirely consistent with the
PTP acting as a Ca2+ release channel to prevent Ca2+ overload
(Elrod et al., 2010). Consistent with this idea, cytosolic [Ca2+]
increases induced by either ATP or depolarizing concentrations
of KCl gave comparable transient increases of mitochondrial
[Ca2+] in adult cortical neurons from wild type and Ppif−/−
mice; while application of the two stimuli together resulted in
much higher levels of mitochondrial [Ca2+] in the Ppif−/− neu-
rons, suggesting that the threshold for PTP activation had been
reached in the wild type but not in the CyPD-null mitochon-
dria in situ. These data indicate that the regulatory role of CyPD
(and thus PTP opening) in Ca2+ homeostasis may be essential
only for relatively large mitochondrial Ca2+ loads (Barsukova
et al., 2011). Mice expressing amyotrophic lateral sclerosis-linked
mutants of superoxide dismutase (SOD) 1 develop a motor neu-
ron disease with many pathological hallmarks seen in patients
(Gurney et al., 1994). Spinal cord mitochondria from these mice
display decreased Ca2+ retention capacity long before onset of
motor weakness and neuronal death (Damiano et al., 2006),
and this was corrected by genetic elimination of the Ppif−/−
gene (Parone et al., 2013). Improved mitochondrial Ca2+ buffer-
ing was matched by improved mitochondrial ATP synthesis and
reduced swelling, attenuation of glial activation, reduction of
misfolded SOD1 aggregates in the spinal cord, and significant
suppression of motor neuron death throughout disease, although
survival was unfortunately not improved (Parone et al., 2013).
Transient PTP openings appear also to be at the basis of
“superoxide flashes” observed with mitochondrially targeted, cir-
cularly permuted yellow fluorescent protein (mt-cpYFP) in a
variety of cell types (Wang et al., 2008, 2013; Fang et al., 2011).
There is an ongoing debate on whether the flashes are in fact
partially or totally due to changes of matrix pH (Schwarzlander
et al., 2011, 2012), although it is fair to say that the measured
matrix alkalinization appears to be way too small to account for
the fluorescence changes of mt-cpYFP (Wei-Lapierre et al., 2013).
The recent finding that Drosophila mitochondria possess a
PTP-related but CsA-insensitive Ca2+ release channel selective for
Ca2+ and H+ (von Stockum et al., 2011) provides a nice model
system, and perhaps the missing link between the PTP of yeast
and mammals (Azzolin et al., 2010). I am confident that it will be
now possible to address the potential role of the PTP as a Ca2+
release channel through inhibition of the “pore function” of ATP
synthase dimers through appropriate drugs and through genetic
manipulation.
COMPLEX I
The PTP has the remarkable feature of being modulated by elec-
tron flow through complex I (Fontaine et al., 1998a), which may
in part be linked to the fact that NADH oxidation favors PTP
opening (Costantini et al., 1996). A specific role of complex I,
however, is suggested by the striking discovery that in mam-
malian mitochondria rotenone can be an effective inhibitor of
the pore (Chauvin et al., 2001; Li et al., 2012). Inhibition of the
PT by rotenone is maximal in mitochondria from tissues that
express low levels of CyPD, where CsA has little inhibitory effect;
while inhibition by CsA is maximal in mitochondria from tis-
sues with high levels of expression of CyPD, where rotenone does
not affect the PTP. Finally, tissues with mitochondria expressing
intermediate levels of CyPD are sensitive to both rotenone and
CsA, with additive effects of the two inhibitors (Li et al., 2012).
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Intriguingly, the inhibitory effect of rotenone is potentiated by Pi,
which is reminiscent of the Pi requirement for inhibition by CsA
(Basso et al., 2008). The concentrations of rotenone required for
PT inhibition matched quite precisely those required to inhibit
respiration, and a similar PT-inhibiting effect was seen with met-
formin, which partially inhibits complex I as well (El Mir et al.,
2000; Guigas et al., 2004). Since rotenone and metformin do not
share common structural features, it appears likely that mod-
ulation of the PTP by inhibition of complex I is indirect, and
possibly mediated by inhibition of complex I-derived reactive
oxygen species (Batandier et al., 2004). An indirect effect is also
suggested by the observations (1) that a Ca2+-dependent (albeit
CsA-insensitive) PT can occur in mitochondria from yeast strains
that do not possess an energy-conserving complex I (Jung et al.,
1997; Yamada et al., 2009; Uribe-Carvajal et al., 2011); (2) that
complex I purified by blue native electrophoresis did not form
Ca2+-activated channels in lipid bilayers under conditions that
instead promote MMC opening after incorporation of complex V
(Giorgio et al., 2013); and (3) that complex I does not colocalize
with ATP synthase oligomers (Davies et al., 2011).
QUINONES
The regulatory effects of quinones on the PTPhas been discovered
in our laboratory in 1998 (Fontaine et al., 1998a,b) and thor-
oughly characterized by Fontaine and Coworkers (Walter et al.,
2000, 2002; Devun et al., 2010). Ub0 (i.e., ubiquinone with-
out a side chain) is the most potent inhibitor of the PTP; the
dose-dependence displays a bell-shaped curve, however, a feature
that is also typical of other inhibitory quinones like decylu-
biquinone (Fontaine et al., 1998a,b; Fontaine and Bernardi, 1999;
Walter et al., 2000). PTP-inducing quinones include idebenone
(Walter et al., 2000) while idebenol (the reduced form) is no
longer effective, suggesting that the effect on the PTP is related to
oxidation-reduction events (Giorgio et al., 2012). The structure–
function relationship of quinones for PTP inhibition/activation
has not been solved, and further complexity arises from the fact
that the same quinone can have opposite effects depending on the
cell type (Devun et al., 2010). It appears possible that, like sub-
stituted maleimides, Ub0 affects PTP formation in part at least
through its ability to form adducts with SH groups, which is not
shared by short-chain quinones. ROS-forming ability of the lat-
ter does not always correlate with their PTP-inducing features
(Devun et al., 2010) and the general mechanism of action of
quinones on the PT remains to be solved.
CONCLUSIONS AND PERSPECTIVES
The findings that (1) dimers of the ATP synthase treated with
Ca2+ generate currents indistinguishable from the MMC–PTP;
(2) channel openings are favored by Bz-423 and thiol oxidants;
(3) channel openings are inhibited by adenine nucleotides and
Mg2+; and (4) monomers lack any channel activity, all represent
strong indications that the PTP forms from a specific, Ca2+-
dependent conformation of the dimers. The FOF1 ATP synthase
readily accommodates key pathophysiological effectors of the PT
since Ca2+, Mg2+, adenine nucleotides, and Pi bind the catalytic
core at F1; and the membrane potential andmatrix pH, which are
key PTP modulators (Bernardi et al., 2006), are also key regula-
tors of the ATP synthase. On the other hand, several regulators
of the PTP (specifically, rotenone and quinones) are not easily
accounted for by the dimer hypothesis, and their mechanism of
action will need further studies. However, I believe that our find-
ings provide a novel and stimulating working hypothesis that
should help address outstanding issues including species-specific
features of the PTP of rats (Ricchelli et al., 2005; Zulian et al.,
2007), yeast (Jung et al., 1997; Manon et al., 1998; Yamada et al.,
2009; Uribe-Carvajal et al., 2011), and Drosophila melanogaster
(von Stockum et al., 2011); and the mystery of Artemia francis-
cana, an anoxia and salt-tolerant brine shrimp whose mitochon-
dria are refractory to PTP opening (Menze et al., 2005, 2010).
Together our results suggest a dual function for complex V, ATP
synthesis and PTP formation. The key enzyme of life appears
therefore to be also the molecular switch that signals the presence
of fully depolarized, dysfunctional mitochondria to promote cell
death (Rasola and Bernardi, 2011) and/or mitophagy (Youle and
Narendra, 2011).
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